Skip to main content

Day: September 24, 2021

American Films Announces Intention to Conduct a 1:5 Reverse Stock Split, Shares to Commence Trading on tZERO ATS in the Fourth Quarter

Latest moves demonstrate company’s commitment to increasing shareholder value by focusing on asset digitization in the form of STO and NFT issuance NEW BOSTON, N.H., Sept. 24, 2021 (GLOBE NEWSWIRE) — American Films, Inc. (OTC: AMFL) today announced that its Board of Directors unanimously approved a 1:5 reverse stock split. The effective date of the reverse stock split will be determined once it has been processed by the Financial Industry Regulatory Authority (“FINRA”). “We believe that the reverse stock split is an important step for the company and its stockholders to optimize our position as we work to execute strategic initiatives across all fronts,” said American Films President and Chief Executive Officer John Carty. “By implementing a reverse stock split, American Films believes it can realize increased incremental demand...

Continue reading

Nanox to Host Live Streaming AI Vision Event

Join the Company on Wednesday October 27th at 8:30am ET to hear about its AI vision and how it can enhance its deep technology Ran Poliakine, Chairman and CEO and Erez Meltzer, Director, will host industry experts and Nanox team members to share the Company’s AI vision of the integration of the AI technologies with the Nanox.ARC and Nanox.SOURCE NEVE ILAN, Israel, Sept. 24, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Ran Poliakine, Chairman and Chief Executive Officer, and Erez Meltzer, Director (appointed CEO effective January 1, 2022), will host a Nanox AI Vision event. Wednesday, October 27, 20218:30am ETPublic link for the event: https://nanox.eventmagix.com/ About Nanox:Nanox, founded by the...

Continue reading

PharmaTher Announces CAD$10 Million Private Placement With Institutional Investors

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has entered into a securities purchase agreement with institutional investors for a private placement of its common shares (“Common Shares”) and warrants to purchase common shares (“Warrants”) for gross proceeds of CAD$10 million (the “Private Placement”). Pursuant to the Private Placement, the Company will issue 15,625,000 Common Shares and Warrants to purchase up to 15,625,000 Common Shares at a purchase price of CAD$0.64 per Common Share and associated Warrant. Each Warrant will entitle the holder to purchase one Common Share at an exercise price of CAD$0.80...

Continue reading

Catalyst Biosciences to Present at the Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that a fireside chat including members of its executive management team will be broadcast as part of the Cantor Global Healthcare Conference at 10:00 am ET on Wednesday, September 29, 2021. To access the webcast of the discussion, please click here. An archived webcast of the discussion will be available for 90 days on the Events and Presentations section of Catalyst’s website. About Catalyst Biosciences, the Protease Medicines companyCatalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare disorders of the complement and coagulation systems. Our protease engineering platform has generated two late-stage clinical programs, including MarzAA, a...

Continue reading

Onconova Therapeutics, Inc. Announces Pricing of $21 Million Public Offering of Common Stock

NEWTOWN, Pa., Sept. 24, 2021 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $4.20 per share. The gross proceeds of the offering to the Company are expected to be $21 million, before deducting the underwriting discounts and commissions and other estimated offering expenses. In addition, Onconova granted the underwriters a thirty-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about September 28, 2021, subject to the satisfaction...

Continue reading

KYN Capital Group Launches Corporate Website

CARSON CITY, NV, Sept. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – KYN Capital Group (OTC: KYNC), home to one of the most awaited crypto exchanges and super apps in the United States, is proud to announce the launch of its corporate website which is now live.    By visiting kyncap.com you can now stay abreast of product launches, investor calls, and key initiatives taking place at the company. You will also find a list of satellite offices, partners, and corporate leaders that are helping to drive the company forward in a new direction. With the launch of its new website, KYN Capital Group has made its vision clear to clients, as well as investors, its path forward under CEO, Rick Wilson.  As stated in a recent announcement, “Rick believes now is the time for KYN Capital Group to solidify its place in the market while also creating...

Continue reading

Clearway Energy Operating LLC, a Subsidiary of Clearway Energy, Inc., Announces Cash Tender Offer and Concurrent Redemption Notice for Any and All of Its Outstanding 5.000% Senior Notes Due 2026

PRINCETON, N.J., Sept. 24, 2021 (GLOBE NEWSWIRE) — Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”), announced that it has commenced a cash tender offer to purchase any and all of the $350 million outstanding aggregate principal amount of its 5.000% senior notes due 2026 (the “2026 Notes”) with the net proceeds from Clearway Operating’s concurrent offering of $350 million in aggregate principal amount of senior notes due 2032 (the “New Notes”), which was also announced today by Clearway Operating. The tender offer is being made pursuant to an offer to purchase, related letter of transmittal and notice of guaranteed delivery, each dated as of September 24, 2021. The tender offer will expire at 5:00 p.m., New York City time, on September 30, 2021...

Continue reading

Draganfly to be Featured on Bloomberg on The RedChip Money Report® September 25th

Los Angeles, CA., Sept. 24, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that an interview with Draganfly Chairman and CEO Cameron Chell will air on The RedChip Money Report® on Bloomberg on September 25, 2021 at 7 p.m. Eastern Time. Bloomberg TV is available in an estimated 73 million homes across the United States. Draganfly was recently featured on The RedChip Money Report® on August 21, 2021. Produced by RedChip Companies Inc., The RedChip Money Report® is an international Investor Relations and media firm with 30 years’ experience focused on Discovering Tomorrow’s Blue Chips Today™. The RedChip Money Report® delivers insightful commentary on small-cap investing, interviews...

Continue reading

Making a lasting impact: Dentsply Sirona announces 5-year partnership agreement with Smile Train and a $5 million donation

Dentsply Sirona, the world’s largest manufacturer of professional dental products, announced the official launch of its partnership with Smile Train, the world’s largest cleft-focused organization. For over 21 years, Smile Train has supported safe and quality cleft care for more than 1.5 million children in over 90 countries around the world. Dentsply Sirona’s commitment aims to advance the future of and access to cleft care. CHARLOTTE, N.C. , Sept. 24, 2021 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), Globally, 1 in 700 babies are born with a cleft lip and/or palate. Clefts can have devastating effects on the quality of life of a child, both physically by compromising the ability to communicate and to eat properly and from social stigma resulting in feelings of anxiety and a lack of self-confidence....

Continue reading

Fortress Technologies Announces Leadership and Board of Directors Transition, Asset Purchase Agreement

TORONTO, Sept. 24, 2021 (GLOBE NEWSWIRE) — Fortress Technologies Inc. (TSX-V: FORT) (the “Company” or “Fortress”) is pleased to announce the appointments of Antonin “AJ” Scalia as Chief Executive Officer and Thomas “Drew” Armstrong as President and Chief Operating Officer. Messrs. Scalia and Armstrong will also replace Joshua Crumb and Michael Costa on the Company’s board of directors (the “Board”). Aydin Kilic, who has served as President and Chief Executive Officer since 2018, has resigned as an officer effective September 20, 2021, and has also resigned from the Board effective September 24, 2021. ​​The Board considered the skills and experience of Messrs. Scalia and Armstrong and is confident the changes to the leadership team will enable the Company to pursue its long-term strategic objectives with new guidance and vision....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.